Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
This study has been completed.
Study NCT00425282   Information provided by SK Life Science

First Received on January 19, 2007.   Last Updated on June 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
Epilepsy, Focal
Seizure Disorder
Complex Partial Seizures
Epilepsy, Complex Partial
Additional conditions recognized in this trial
Epilepsies, Partial
Seizures
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
RWJ-333369
Sponsors listed in this trial
SK Life Science


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services